(Q43031474)

12 November 2017

title

Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

placebo-controlled trial

1 reference

15

Keiji Wakabayashi

1 reference

12 November 2017

Hideki Ueno

1

1 reference

12 November 2017

Tosiya Sato

2

1 reference

12 November 2017

Seiichiro Yamamoto

3

1 reference

12 November 2017

Katsuaki Tanaka

4

1 reference

12 November 2017

Shinichi Ohkawa

5

1 reference

12 November 2017

Hitoshi Takagi

6

1 reference

12 November 2017

Osamu Yokosuka

7

1 reference

12 November 2017

Junji Furuse

8

1 reference

12 November 2017

Hidetsugu Saito

9

1 reference

12 November 2017

Akira Sawaki

10

1 reference

12 November 2017

Hiroshi Kasugai

11

1 reference

12 November 2017

Yukio Osaki

12

1 reference

12 November 2017

Shigetoshi Fujiyama

13

1 reference

12 November 2017

Keiko Sato

14

1 reference

12 November 2017

Takuji Okusaka

16

1 reference

12 November 2017

publication date

1 October 2006

1 reference

12 November 2017

1 reference

12 November 2017

volume

97

1 reference

12 November 2017

issue

10

1 reference

12 November 2017

page(s)

1105-1110

1 reference

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Lactoferrin—a multifunctional protein with antimicrobial properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Antibacterial and antiviral effects of milk proteins and derivatives thereof

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Dose-response trial of lactoferrin in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Significance of specific antibody assay for genotyping of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

A Multiple Testing Procedure for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

No detectable transfer of dietary lactoferrin or its functional fragments to portal blood in healthy adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Protection against infections by oral lactoferrin: evaluation in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Characterization of pseudotype VSV possessing HCV envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Randomized placebo-controlled trial of interferon alpha-2b plus ribavirin with and without lactoferrin for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00274.X

10.1111/J.1349-7006.2006.00274.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference